SI1115725T1 - Tetrahydropyridoethers - Google Patents
TetrahydropyridoethersInfo
- Publication number
- SI1115725T1 SI1115725T1 SI9930207T SI9930207T SI1115725T1 SI 1115725 T1 SI1115725 T1 SI 1115725T1 SI 9930207 T SI9930207 T SI 9930207T SI 9930207 T SI9930207 T SI 9930207T SI 1115725 T1 SI1115725 T1 SI 1115725T1
- Authority
- SI
- Slovenia
- Prior art keywords
- tetrahydropyridoethers
- naphthyridine
- imidazo
- methoxyethoxy
- tetrahydro
- Prior art date
Links
- PWILYDZRJORZDR-MISYRCLQSA-N (7r,8r,9r)-7-(2-methoxyethoxy)-2,3-dimethyl-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridin-8-ol Chemical compound C1([C@@H]2[C@@H](O)[C@@H](C3=C(C4=NC(C)=C(C)N4C=C3)N2)OCCOC)=CC=CC=C1 PWILYDZRJORZDR-MISYRCLQSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000004211 gastric acid Anatomy 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98117988 | 1998-09-23 | ||
| DE19843504 | 1998-09-23 | ||
| PCT/EP1999/006899 WO2000017200A1 (en) | 1998-09-23 | 1999-09-17 | Tetrahydropyridoethers |
| EP99948776A EP1115725B1 (en) | 1998-09-23 | 1999-09-17 | Tetrahydropyridoethers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1115725T1 true SI1115725T1 (en) | 2003-06-30 |
Family
ID=26049024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9930207T SI1115725T1 (en) | 1998-09-23 | 1999-09-17 | Tetrahydropyridoethers |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US6436953B1 (enExample) |
| EP (1) | EP1115725B1 (enExample) |
| JP (1) | JP4145492B2 (enExample) |
| KR (1) | KR100668400B1 (enExample) |
| CN (2) | CN1155598C (enExample) |
| AT (1) | ATE231862T1 (enExample) |
| AU (1) | AU763463B2 (enExample) |
| BG (1) | BG65195B1 (enExample) |
| BR (1) | BR9914044A (enExample) |
| CA (1) | CA2344251A1 (enExample) |
| CZ (1) | CZ292335B6 (enExample) |
| DE (1) | DE69905178T2 (enExample) |
| DK (1) | DK1115725T3 (enExample) |
| EA (1) | EA005377B1 (enExample) |
| EE (1) | EE04677B1 (enExample) |
| ES (1) | ES2191464T3 (enExample) |
| GE (1) | GEP20032926B (enExample) |
| HK (1) | HK1038360B (enExample) |
| HR (1) | HRP20010224A2 (enExample) |
| HU (1) | HUP0102990A3 (enExample) |
| ID (1) | ID28896A (enExample) |
| IL (2) | IL142063A0 (enExample) |
| NO (1) | NO317304B1 (enExample) |
| NZ (1) | NZ510610A (enExample) |
| PL (1) | PL193616B1 (enExample) |
| PT (1) | PT1115725E (enExample) |
| RS (1) | RS50145B (enExample) |
| SI (1) | SI1115725T1 (enExample) |
| SK (1) | SK285165B6 (enExample) |
| TR (1) | TR200100805T2 (enExample) |
| WO (1) | WO2000017200A1 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000017200A1 (en) | 1998-09-23 | 2000-03-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrahydropyridoethers |
| AU3966600A (en) * | 1999-04-17 | 2000-11-02 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Haloalkoxy imidazonaphthyridines |
| CA2721484A1 (en) * | 1999-05-12 | 2000-11-12 | President And Fellows Of Harvard College | Dopamine transporter imaging agents |
| WO2001072757A1 (en) * | 2000-03-29 | 2001-10-04 | Altana Pharma Ag | Tricyclic imidazopyridines |
| JP2003528878A (ja) * | 2000-03-29 | 2003-09-30 | アルタナ ファルマ アクチエンゲゼルシャフト | イミダゾピリジン誘導体のプロドラッグ |
| AU2002210563B2 (en) * | 2000-10-25 | 2007-03-01 | Altana Pharma Ag | Polysubstituted imidazopyridines as gastric secretion inhibitors |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| CZ20032398A3 (cs) * | 2001-03-08 | 2004-02-18 | Astrazeneca Ab | Nové použití derivátů 6-karboxamidoimidazo [1,2-a] pyridinu |
| ATE336493T1 (de) | 2001-08-02 | 2006-09-15 | Altana Pharma Ag | Tricyclische epoxide |
| CN1656096A (zh) * | 2001-08-03 | 2005-08-17 | 奥坦纳医药公司 | 用于治疗胃肠病症的烷基－取代的咪唑吡啶 |
| US20040235882A1 (en) * | 2001-08-03 | 2004-11-25 | Jorg Senn-Bilfinger | Amino-substituted imidazopyridines for the treatment of gastrointestial diseases |
| HRP20040834A2 (en) | 2002-02-15 | 2005-06-30 | Altana Pharma Ag | Tricyclic n-acyl compounds |
| MY140561A (en) * | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| WO2003094967A2 (en) * | 2002-05-07 | 2003-11-20 | Altana Pharma Ag | New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders |
| HRP20050528A2 (en) | 2002-11-19 | 2006-06-30 | Altana Pharma Ag | 8-substituted imidazopyridines |
| ES2312844T3 (es) | 2002-12-12 | 2009-03-01 | Nycomed Gmbh | Medicamento de combinacion de r, r-formoterol y ciclesonida. |
| PL375933A1 (en) * | 2002-12-20 | 2005-12-12 | Altana Pharma Ag | 8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines |
| BRPI0407541A (pt) * | 2003-02-17 | 2006-02-14 | Altana Pharma Ag | combinações e uso de compostos farmaceuticamente ativos selecionados |
| EA009985B1 (ru) | 2003-03-10 | 2008-04-28 | Никомед Гмбх | Новый способ получения рофлумиласта |
| TW200503783A (en) * | 2003-04-11 | 2005-02-01 | Altana Pharma Ag | Oral pharmaceutical preparation for proton pump antagonists |
| SA04250092B1 (ar) * | 2003-05-14 | 2008-05-04 | التانا فاروا ايه جي | مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً |
| CA2526566A1 (en) * | 2003-05-27 | 2004-12-09 | Altana Pharma Ag | Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility |
| CA2537182A1 (en) * | 2003-08-29 | 2005-03-10 | Dynogen Pharmaceuticals, Inc. | Compositions useful for treating gastrointestinal motility disorders |
| WO2005025578A1 (en) | 2003-09-16 | 2005-03-24 | Altana Pharma Ag | Use of ciclesonide for the treatment of respiratory diseases |
| EP1682133A1 (en) * | 2003-11-03 | 2006-07-26 | AstraZeneca AB | Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux |
| WO2005058894A1 (en) | 2003-12-19 | 2005-06-30 | Altana Pharma Ag | Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives |
| AR047605A1 (es) * | 2004-02-17 | 2006-01-25 | Altana Pharma Ag | Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos. |
| DK1784404T3 (da) | 2004-09-03 | 2012-02-13 | Yuhan Corp | Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling |
| DK1784402T3 (da) | 2004-09-03 | 2011-11-14 | Yuhan Corp | Pyrrolo[3,2-c]pyridinderivater samt fremgangsmåder til deres fremstilling |
| ES2426920T3 (es) | 2004-09-03 | 2013-10-25 | Yuhan Corporation | Derivados de pirrolo[3,2-B]piridina y procesos para su preparación |
| ES2421916T3 (es) * | 2005-03-16 | 2013-09-06 | Nycomed Gmbh | Forma farmacéutica de sabor enmascarado que contiene roflumilast |
| EP2080513A1 (en) | 2008-01-16 | 2009-07-22 | Schraermeyer, Ulrich, Prof. Dr. rer. nat | Tetrahydropyridoethers for treatment of AMD |
| EP2452680B1 (en) | 2009-07-09 | 2019-12-18 | RaQualia Pharma Inc. | Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility |
| WO2012027240A1 (en) * | 2010-08-23 | 2012-03-01 | Schering Corporation | Fused tricyclic inhibitors of mammalian target of rapamycin |
| BR112014031396B1 (pt) * | 2012-06-15 | 2019-11-26 | Bio Pharm Solutions Co Ltd | composto de sulfamato de fenilalquila e composição de relaxante muscular compreendendo o mesmo |
| US20160235724A1 (en) | 2013-10-08 | 2016-08-18 | Katairo Gmbh | Tetrahydropyridoethers for the treatment of stargardt's disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4468400A (en) * | 1982-12-20 | 1984-08-28 | Schering Corporation | Antiulcer tricyclic imidazo [1,2-a]pyridines |
| EP0370056A1 (de) | 1987-07-16 | 1990-05-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Neue diazole |
| SE9401197D0 (sv) * | 1994-04-11 | 1994-04-11 | Astra Ab | Active compounds |
| JPH10505332A (ja) * | 1994-07-28 | 1998-05-26 | ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング | アシルイミダゾピリジン |
| BR9807883A (pt) * | 1997-03-24 | 2000-02-22 | Byk Gulden Lomberg Chem Fab | Compostos de tetraidropirido |
| HUP0001555A3 (en) * | 1997-10-30 | 2001-01-29 | Altana Pharma Ag | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation |
| WO2000017200A1 (en) | 1998-09-23 | 2000-03-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrahydropyridoethers |
-
1999
- 1999-09-17 WO PCT/EP1999/006899 patent/WO2000017200A1/en not_active Ceased
- 1999-09-17 SK SK399-2001A patent/SK285165B6/sk not_active IP Right Cessation
- 1999-09-17 ID IDW20010682A patent/ID28896A/id unknown
- 1999-09-17 PT PT99948776T patent/PT1115725E/pt unknown
- 1999-09-17 BR BR9914044-6A patent/BR9914044A/pt not_active Application Discontinuation
- 1999-09-17 KR KR1020017003553A patent/KR100668400B1/ko not_active Expired - Fee Related
- 1999-09-17 JP JP2000574109A patent/JP4145492B2/ja not_active Expired - Lifetime
- 1999-09-17 CA CA002344251A patent/CA2344251A1/en not_active Abandoned
- 1999-09-17 EE EEP200100172A patent/EE04677B1/xx not_active IP Right Cessation
- 1999-09-17 EP EP99948776A patent/EP1115725B1/en not_active Expired - Lifetime
- 1999-09-17 CZ CZ20011082A patent/CZ292335B6/cs not_active IP Right Cessation
- 1999-09-17 GE GEAP19995786A patent/GEP20032926B/en unknown
- 1999-09-17 HU HU0102990A patent/HUP0102990A3/hu unknown
- 1999-09-17 EA EA200100315A patent/EA005377B1/ru not_active IP Right Cessation
- 1999-09-17 PL PL99346617A patent/PL193616B1/pl not_active IP Right Cessation
- 1999-09-17 CN CNB998112992A patent/CN1155598C/zh not_active Expired - Fee Related
- 1999-09-17 NZ NZ510610A patent/NZ510610A/en unknown
- 1999-09-17 ES ES99948776T patent/ES2191464T3/es not_active Expired - Lifetime
- 1999-09-17 DK DK99948776T patent/DK1115725T3/da active
- 1999-09-17 HK HK02100042.6A patent/HK1038360B/en not_active IP Right Cessation
- 1999-09-17 TR TR2001/00805T patent/TR200100805T2/xx unknown
- 1999-09-17 IL IL14206399A patent/IL142063A0/xx active IP Right Grant
- 1999-09-17 AT AT99948776T patent/ATE231862T1/de not_active IP Right Cessation
- 1999-09-17 DE DE69905178T patent/DE69905178T2/de not_active Expired - Lifetime
- 1999-09-17 SI SI9930207T patent/SI1115725T1/xx unknown
- 1999-09-17 HR HR20010224A patent/HRP20010224A2/hr not_active Application Discontinuation
- 1999-09-17 AU AU61920/99A patent/AU763463B2/en not_active Expired
- 1999-09-17 US US09/582,212 patent/US6436953B1/en not_active Expired - Lifetime
- 1999-09-17 RS YUP-214/01A patent/RS50145B/sr unknown
- 1999-09-17 CN CNB2004100384351A patent/CN100506821C/zh not_active Expired - Fee Related
-
2001
- 2001-02-19 BG BG105270A patent/BG65195B1/bg unknown
- 2001-03-12 NO NO20011243A patent/NO317304B1/no not_active IP Right Cessation
- 2001-03-18 IL IL142063A patent/IL142063A/en not_active IP Right Cessation
-
2002
- 2002-03-25 US US10/103,733 patent/US6696460B2/en not_active Expired - Lifetime
-
2004
- 2004-02-23 US US10/783,512 patent/US7105676B2/en not_active Expired - Lifetime
-
2006
- 2006-07-27 US US11/493,707 patent/US7393860B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL346617A1 (en) | Tetrahydropyridoethers | |
| ZA200108855B (en) | Method for the preparation of citalopram. | |
| ZA200108854B (en) | Method for the preparation of citalopram. | |
| EE04676B1 (et) | Imidasopridiini derivaadid, mis inhibeerivad maohappesekretsiooni, protsess nende valmistamiseks ning nende kasutamine | |
| PL347189A1 (en) | Method for the preparation of citalopram | |
| IL145615A0 (en) | Method for the preparation of citalopram | |
| GB2360281B (en) | Method for the preparation of citalopram | |
| ZA200106683B (en) | Method for the preparation of citalopram. | |
| ZA200206699B (en) | Method for the preparation of citalopram. | |
| ZA99493B (en) | Method for the isolation of nucleic acid. | |
| AU7902400A (en) | Method for the preparation of 5-carboxyphthalide | |
| HUP0203635A3 (en) | Method for the preparation of citalopram | |
| AU1056302A (en) | Polysubstituted imidazopyridines as gastric secretion inhibitors | |
| HUP0203840A3 (en) | Method for the preparation of citalopram | |
| ZA973400B (en) | Method for the manufacture of brushes. | |
| IL143875A0 (en) | Method for the preparation of citalopram | |
| AU1130901A (en) | Method for the preparation of 5-carboxyphthalide | |
| ZA200102822B (en) | Method for the preparation of citalopram. | |
| ZA200106687B (en) | Method for the preparation of citalopram. | |
| AUPQ075599A0 (en) | Method for direct electromagnetic-ultrasonic measurements of the permeability ofrocks | |
| SI1123284T1 (en) | Method for the preparation of citalopram | |
| ZA99354B (en) | Method of making sulfanatophenyl substituted porphines. |